In HIV/AIDS Fight, Tough Choices Loom For Thailand

Law360, New York (August 16, 2006, 12:00 AM EDT) -- Weeks after protestors rallied against British drug maker GlaxoSmithKline’s efforts to patent an anti-retroviral in Thailand, the World Bank warned in a report Wednesday that the country must decide whether to shell out market prices for patented drugs as a rising number of Thais living with HIV/AIDS are forced to turn to so-called second-line drugs.

The report, “The Economics of Effective AIDS Treatment: Evaluating Policy Options for Thailand,” praised Thailand's drug provision program, the National Access to Antiretroviral Program for People Living with HIV/AIDS (NAPHA), which...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.